These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20631810)

  • 1. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.
    Guss AM; Roeselers G; Newton IL; Young CR; Klepac-Ceraj V; Lory S; Cavanaugh CM
    ISME J; 2011 Jan; 5(1):20-9. PubMed ID: 20631810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
    Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
    PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens.
    Zemanick ET; Wagner BD; Sagel SD; Stevens MJ; Accurso FJ; Harris JK
    PLoS One; 2010 Nov; 5(11):e15101. PubMed ID: 21152087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
    Kolak M; Karpati F; Monstein HJ; Jonasson J
    Int J Med Microbiol; 2003 Aug; 293(4):309-17. PubMed ID: 14503795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.
    Bittar F; Richet H; Dubus JC; Reynaud-Gaubert M; Stremler N; Sarles J; Raoult D; Rolain JM
    PLoS One; 2008 Aug; 3(8):e2908. PubMed ID: 18682840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.
    Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Bruce KD
    J Clin Microbiol; 2004 Nov; 42(11):5176-83. PubMed ID: 15528712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culture enriched molecular profiling of the cystic fibrosis airway microbiome.
    Sibley CD; Grinwis ME; Field TR; Eshaghurshan CS; Faria MM; Dowd SE; Parkins MD; Rabin HR; Surette MG
    PLoS One; 2011; 6(7):e22702. PubMed ID: 21829484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing.
    Armougom F; Bittar F; Stremler N; Rolain JM; Robert C; Dubus JC; Sarles J; Raoult D; La Scola B
    Eur J Clin Microbiol Infect Dis; 2009 Sep; 28(9):1151-4. PubMed ID: 19449045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.
    Flight WG; Smith A; Paisey C; Marchesi JR; Bull MJ; Norville PJ; Mutton KJ; Webb AK; Bright-Thomas RJ; Jones AM; Mahenthiralingam E
    J Clin Microbiol; 2015 Jul; 53(7):2022-9. PubMed ID: 25878338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.
    Rudkjøbing VB; Thomsen TR; Alhede M; Kragh KN; Nielsen PH; Johansen UR; Givskov M; Høiby N; Bjarnsholt T
    J Clin Microbiol; 2011 Dec; 49(12):4352-5. PubMed ID: 22012018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
    Delhaes L; Monchy S; Fréalle E; Hubans C; Salleron J; Leroy S; Prevotat A; Wallet F; Wallaert B; Dei-Cas E; Sime-Ngando T; Chabé M; Viscogliosi E
    PLoS One; 2012; 7(4):e36313. PubMed ID: 22558432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
    Tunney MM; Field TR; Moriarty TF; Patrick S; Doering G; Muhlebach MS; Wolfgang MC; Boucher R; Gilpin DF; McDowell A; Elborn JS
    Am J Respir Crit Care Med; 2008 May; 177(9):995-1001. PubMed ID: 18263800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
    Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Kehagia V; Connett GJ; Bruce KD
    J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.